Skip to main content
. Author manuscript; available in PMC: 2019 Feb 4.
Published in final edited form as: Expert Rev Anticancer Ther. 2010 Jul;10(7):997–1008. doi: 10.1586/era.10.88

Figure 4. Serum magnesium and potassium (mmol/l) recorded at the time patients presented for romidepsin dosing on days 1, 8 and 15 of treatment.

Figure 4.

Per protocol, thresholds for electrolyte replacement were 0.85 mmol/l for magnesium and 4.0 mmol/l for potassium (denoted by quadrants).